Notably, we demonstrated that treatment of primary fibroblasts with FAPα/EBV-LMP1-containing exosomes derived from NPC cells activated fibroblasts by stimulating the functions of YAP1 and FAPα, thereby enhancing fibrotic responses and tumor growth in mouse xenografts. This evidence concerns the gene PDLIM7 and nasopharyngeal carcinoma.